A phase II study of belumosudil for chronic graft-versus-host disease in patients who failed at least one line of systemic therapy in China.
Saved in:
| Title: | A phase II study of belumosudil for chronic graft-versus-host disease in patients who failed at least one line of systemic therapy in China. |
|---|---|
| Authors: | Wang, Ying1 (AUTHOR), Wu, Depei1 (AUTHOR) wudepei@suda.edu.cn, Zhang, Xiang1 (AUTHOR), Li, Yuhua2 (AUTHOR), He, Yanjie2 (AUTHOR), Liu, Qifa3 (AUTHOR), Xuan, Li3 (AUTHOR), Li, Zhenyu4 (AUTHOR), Qi, Kunming4 (AUTHOR), Sun, Yuqian5 (AUTHOR), Wang, Shunqing6 (AUTHOR), Mo, Wenjian6 (AUTHOR), Gao, Lei7 (AUTHOR), Hua, Ye8 (AUTHOR), Wang, Yu8 (AUTHOR), Zhang, Ying8 (AUTHOR) |
| Source: | BMC Medicine. 3/26/2024, Vol. 22 Issue 1, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
